- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Screening drug target combinations in disease-related molecular networks ; volume:20 ; number:7 ; day:1 ; month:5 ; year:2019 ; pages:129-138 ; date:5.2019
BMC bioinformatics ; 20, Heft 7 (1.5.2019), 129-138, 5.2019
- Classification
-
Medizin, Gesundheit
- Creator
-
Luo, Min
Jiao, Jianfeng
Wang, Ruiqi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-019-2730-8
- URN
-
urn:nbn:de:101:1-2019061021490423454148
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luo, Min
- Jiao, Jianfeng
- Wang, Ruiqi
- SpringerLink (Online service)
Other Objects (12)
Network target for screening synergistic drug combinations with application to traditional Chinese medicine
Leishmaniaamastigotes as targets for drug screening
Expression proteomics study to determine metallodrug targets and optimal drug combinations
Drug combinations screening using a Bayesian ranking approach based on dose–response models
Finding multiple target optimal intervention in disease‐related molecular network
Network-based prediction of drug combinations
Release adjustment of drug combinations with different drug solubility
Release adjustment of drug combinations with different drug solubility
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
Dosage and Dose Schedule Screening of Drug Combinations in Agent-Based Models Reveals Hidden Synergies
Screening of the Pandemic Response Box library identified promising compound candidate drug combinations against extensively drug-resistant Acinetobacter baumannii
Network target for screening synergistic drug combinations with application to traditional Chinese medicine
Leishmaniaamastigotes as targets for drug screening
Expression proteomics study to determine metallodrug targets and optimal drug combinations
Drug combinations screening using a Bayesian ranking approach based on dose–response models
Finding multiple target optimal intervention in disease‐related molecular network
Network-based prediction of drug combinations
Release adjustment of drug combinations with different drug solubility
Release adjustment of drug combinations with different drug solubility
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
Dosage and Dose Schedule Screening of Drug Combinations in Agent-Based Models Reveals Hidden Synergies
Screening of the Pandemic Response Box library identified promising compound candidate drug combinations against extensively drug-resistant Acinetobacter baumannii
Network target for screening synergistic drug combinations with application to traditional Chinese medicine
Leishmaniaamastigotes as targets for drug screening
Expression proteomics study to determine metallodrug targets and optimal drug combinations
Drug combinations screening using a Bayesian ranking approach based on dose–response models
Finding multiple target optimal intervention in disease‐related molecular network
Network-based prediction of drug combinations
Release adjustment of drug combinations with different drug solubility
Release adjustment of drug combinations with different drug solubility
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
Dosage and Dose Schedule Screening of Drug Combinations in Agent-Based Models Reveals Hidden Synergies